NCIt definition : A human monoclonal antibody directed against the negative immunoregulatory human cell
receptor programmed cell death protein 1 (PD-1; PDCD1; CD279), with potential immune
checkpoint inhibitory and antineoplastic activities. Upon administration, zeluvalimab
targets, binds to and inhibits PD-1 and its downstream signaling pathways. This may
restore immune function through the activation of T-cells and T-cell-mediated immune
responses against tumor cells. PD-1, a transmembrane protein in the immunoglobulin
superfamily (IgSF) expressed on T-cells, functions as an immune checkpoint that negatively
regulates T-cell activation and effector function when activated by its ligands, programmed
cell death-1 ligand 1 (PD-L1; B7-H1; CD274) and 2 (PD-L2); it plays an important role
in tumor evasion from host immunity.;
Semantic type(s)